Diagnostic performance of two point-of-care tests for anti-HCV detection

Hepatitis Monthly

Volumn 13, Issue 9, 2013, Pages

  da Rosa, Lígia ^a   Dantas Corrêa, Esther Buzaglo ^a   Narciso Schiavon, Janaína Luz ^a   Schiavon, Leonardo de Lucca ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Diagnosis; Hepatitis C; Point of care systems

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIBODY;

ADULT; ARTICLE; CASE CONTROL STUDY; CHEMOLUMINESCENCE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEPATITIS C; HEPATITIS C RAPID TEST; HEPATITIS C VIRUS; HIV RAPID TEST; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; POINT OF CARE TESTING; POLYMERASE CHAIN REACTION; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

EID: 84884956485     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.12274     Document Type: Article

References (14)

1. Lavanchy D. The global burden of hepatitis C. Liver Int. 2009;29:74-81.
2. Hoofnagle JH. Hepatitis C: the clinical spectrum of disease. Hepatology. 1997;26(3 Suppl 1):15S-20S.
3. Hutin Y, Kitler M, Dore G, Perz J, Armstrong G, Dusheiko G, et al. Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol. 2004;44(1):20-29.
4. Ferreira-Gonzalez A, Shiffman ML, editors.Use of diagnostic testing for managing hepatitis C virus infection. 2004; Copyright© 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.
5. Tucker JD, Bien CH, Peeling RW. Point-of-care testing for sexually transmitted infections: recent advances and implications for disease control. Curr Opin Infect Dis. 2013;26(1):73-79.
6. OraQuick HCV Rapid Antibody Test - P080027/S001. Available from: Available from: http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm246401.htm.
7. Lee SR, Kardos KW, Schiff E, Berne CA, Mounzer K, Banks AT, et al. Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid. J Virol Methods. 2011;172(12):27-31.
8. Lee SR, Yearwood GD, Guillon GB, Kurtz LA, Fischl M, Friel T, et al. Evaluation of a rapid, point-of-care test device for the diagnosis of hepatitis C infection. J Clin Virol. 2010;48(1):15-7.
9. Smith BD, Teshale E, Jewett A, Weinbaum CM, Neaigus A, Hagan H, et al. Performance of Premarket Rapid Hepatitis C Virus Antibody Assays in 4 National Human Immunodeficiency Virus Behavioral Surveillance System Sites. Clin Infect Dis. 2011;53(8):780-6.
10. Hui AY, Chan FK, Chan PK, Tam JS, Sung JJ. Evaluation of anew rapid whole-blood serological test for hepatitis c virus. Acta Virol. 2002;46(1):47-8.
11. Montebugnoli L, Borea G, Miniero R, Sprovieri G. A rapid test for the visual detection of anti-hepatitis C virus antibodies in whole blood. Clin Chim Acta. 1999;288(1-2):91-6.
12. Shivkumar S, Peeling R, Jafari Y, Joseph L, Pant Pai N. Accuracy of Rapid and Point-of-Care Screening Tests for Hepatitis CA Systematic Review and Meta-analysis. Ann Intern Med. 2012;157(8):558-66.
13. Ivantes CAP, Silva D, Messias-Reason I. High prevalence of hepatitis C associated with familial history of hepatitis in a small town of south Brazil: efficiency of the rapid test for epidemiological survey. Braz J Infect Dis. 2010;14:483-8.
14. Pai NP, Sollis K, Peeling RW. Rapid hepatitis C tests: better than the gold standard? Expert Rev Mol Diagn. 2013;13(3):221-3.